Sudarshan Pharma Says Proposed 9.5% Stake Acquisition in US Firm Under Due Diligence
New Delhi [India], September 15: Sudarshan Pharma Industries Ltd has provided an update on its proposed acquisition of a 9.5% equity stake in US-based Med Therapy Biotechnology Inc., stating that the transaction is currently under due diligence. In a regulatory filing dated September 15, the company said the proposal to acquire the 9.5% stake in…
Read More “Sudarshan Pharma Says Proposed 9.5% Stake Acquisition in US Firm Under Due Diligence” »
